Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001477932-23-006094
Filing Date
2023-08-14
Accepted
2023-08-14 16:10:49
Documents
1
Period of Report
2023-08-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 4054
  Complete submission text file 0001477932-23-006094.txt   5853
Mailing Address 4040 MACARTHUR BLVD. SUITE 210 NEWPORT BEACH CA 92660
Business Address 4040 MACARTHUR BLVD. SUITE 210 NEWPORT BEACH CA 92660 949-260-1700
Strathspey Crown Holdings Group, LLC (Reporting) CIK: 0001557024 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40021 | Film No.: 231170165

Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Issuer) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations